Latest filing published 10 Mar 2026 for CONMED Corp.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Brent Lalomia: trading record in brief
Brent Lalomia, listed as chief executive, appears in our data through filings on CONMED Corp shares, published by SEC (Form 4). Between 17 June 2022 and 6 March 2026, the trades on record add up to 13 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 10 March 2026, the filings show a share grant worth €894 in CONMED Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brent Lalomia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 75 shares0Common StockSEC:0000816956-26-000029:0
- 75 shares0Common StockSEC:0001127602-25-009019:0
- 75 shares0Common StockSEC:0001127602-24-009313:0
- 250 shares0Common StockSEC:0001127602-23-019194:0
- 75 shares0Common StockSEC:0001127602-23-009539:0
- 0.737 shares@ US$97.693100.0% of flowCommon StockSEC:0001127602-22-019039:0
- 250 shares0Common StockSEC:0001127602-22-017957:0
7 of 7 declarations
